 CAMBRIDGE, Mass., May 10, 2021 GLOBE NEWSWIRE -- Cue Biopharma, Inc. NASDAQ: CUE, a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics designed to selectively engage and modulate targeted T cells directly within the patients body, announced today it will host a conference call and webcast to provide a business update on Monday, May 17, 2021 at 4:30 p.m. EDT. Live and archived versions of the event can be accessed via the Companys website. 